These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 24532163)

  • 21. The derived neutrophil-lymphocyte ratio and the neutrophil-lymphocyte ratio are related to poor prognosis in Hodgkin lymphoma patients.
    Shen QQ; Gao J; Tao H; Wang ST; Wang FJ; Chen YY; Zhang X; Jia YQ
    Am J Blood Res; 2021; 11(1):100-110. PubMed ID: 33796397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prognostic role of the change in albumin-derived neutrophil-to-lymphocyte ratio during neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
    Pan Z; Wang Y; Li S; Cai H; Guan G
    Biomol Biomed; 2024 May; 24(3):612-624. PubMed ID: 38041687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor.
    Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
    Oncotarget; 2017 Feb; 8(8):12891-12901. PubMed ID: 28039452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Significance of Neutrophil-to-lymphocyte Ratio in the Framework of the 8th TNM Edition for Breast Cancer.
    Ferroni P; Roselli M; Buonomo OC; Spila A; Portarena I; Laudisi A; Valente MG; Pirillo SP; Fortunato L; Costarelli L; Cavaliere F; Guadagni F
    Anticancer Res; 2018 Aug; 38(8):4705-4712. PubMed ID: 30061239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prognostic value of preoperative derived neutrophil-to-lymphocyte ratio in patients undergoing total laryngectomy with laryngeal carcinoma.
    Song S; Chen H; Dong W; Zhou H
    Acta Otolaryngol; 2019 Mar; 139(3):294-298. PubMed ID: 30882257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Peripheral Blood Neutrophil-To-Lymphocyte Ratio Is Superior to the Lymphocyte-To-Monocyte Ratio for Predicting the Long-Term Survival of Triple-Negative Breast Cancer Patients.
    Jia W; Wu J; Jia H; Yang Y; Zhang X; Chen K; Su F
    PLoS One; 2015; 10(11):e0143061. PubMed ID: 26580962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Derived neutrophil to lymphocyte ratio and monocyte to lymphocyte ratio may be better biomarkers for predicting overall survival of patients with advanced gastric cancer.
    Song S; Li C; Li S; Gao H; Lan X; Xue Y
    Onco Targets Ther; 2017; 10():3145-3154. PubMed ID: 28706446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients.
    Absenger G; Szkandera J; Pichler M; Stotz M; Arminger F; Weissmueller M; Schaberl-Moser R; Samonigg H; Stojakovic T; Gerger A
    Br J Cancer; 2013 Jul; 109(2):395-400. PubMed ID: 23820252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Derived Neutrophil-to-Lymphocyte Ratio Is an Independent Prognostic Factor in Transplantation Ineligible Patients with Multiple Myeloma.
    Lee GW; Park SW; Go SI; Kim HG; Kim MK; Min CK; Kwak JY; Bae SB; Yoon SS; Lee JJ; Kim KH; Nam SH; Mun YC; Kim HJ; Bae SH; Shin HJ; Lee JH; Park JS; Jeong SH; Lee MH; Lee HS; Park KW; Lee WS; Lee SM; Lee JO; Hyun MS; Jo DY; Lim SN; Lee JH; Kim H; Cho DY; Do YR; Kim JA; Park SK; Kim JS; Kim SJ; Yi HG; Moon JH; Choi CW; Kim SH; Kim BS; Park MR; Shim H; Song MK; Kim Y; Kim K
    Acta Haematol; 2018; 140(3):146-156. PubMed ID: 30253397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet/Lymphocyte Ratio Is Superior to Neutrophil/Lymphocyte Ratio as a Predictor of Chemotherapy Response and Disease-free Survival in Luminal B-like (HER2
    Hu Y; Wang S; Ding N; Li N; Huang J; Xiao Z
    Clin Breast Cancer; 2020 Aug; 20(4):e403-e409. PubMed ID: 32201163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients.
    Graziano V; Grassadonia A; Iezzi L; Vici P; Pizzuti L; Barba M; Quinzii A; Camplese A; Di Marino P; Peri M; Veschi S; Alberti S; Gamucci T; Di Gioacchino M; De Tursi M; Natoli C; Tinari N
    Breast; 2019 Apr; 44():33-38. PubMed ID: 30611095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased derived neutrophil-to-lymphocyte ratio and Breast Imaging-Reporting and Data System classification predict poor survival in patients with non-distant metastatic HER2+ breast cancer treated with neoadjuvant chemotherapy.
    Li Y; Shao Y; Bai L; Zhou X
    Cancer Manag Res; 2018; 10():3841-3847. PubMed ID: 30288115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of hypertension on preoperative neutrophil-lymphocyte ratio evaluation of prognosis of renal cell carcinoma.
    Sun J; Ning H; Sun J; Qu X
    Urol Oncol; 2016 May; 34(5):239.e9-15. PubMed ID: 26803433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of pre-treatment neutrophil: lymphocyte ratio in Japanese patients with breast cancer.
    Nakano K; Hosoda M; Yamamoto M; Yamashita H
    Anticancer Res; 2014 Jul; 34(7):3819-24. PubMed ID: 24982408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pretreatment neutrophil/lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients.
    Azab B; Shah N; Radbel J; Tan P; Bhatt V; Vonfrolio S; Habeshy A; Picon A; Bloom S
    Med Oncol; 2013 Mar; 30(1):432. PubMed ID: 23283648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic value of preoperative inflammatory markers in patients with glioma: a multicenter cohort study.
    Zheng SH; Huang JL; Chen M; Wang BL; Ou QS; Huang SY
    J Neurosurg; 2018 Sep; 129(3):583-592. PubMed ID: 29099300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The value of blood biomarkers of progression and prognosis in ALK-positive patients with non-small cell lung cancer treated with crizotinib.
    Yang Y; Xu H; Yang G; Yang L; Li J; Wang Y
    Asia Pac J Clin Oncol; 2020 Feb; 16(1):63-69. PubMed ID: 31721468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma.
    Troppan K; Deutsch A; Gerger A; Stojakovic T; Beham-Schmid C; Wenzl K; Neumeister P; Pichler M
    Br J Cancer; 2014 Jan; 110(2):369-74. PubMed ID: 24357794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The utility of pretreatment systemic inflammatory response biomarkers on overall survival of cervical cancer patients stratified by clinical staging.
    Santos Thuler LC; Reis Wariss B; Nogueira-Rodrigues A; de Melo AC; Bergmann A
    Eur J Obstet Gynecol Reprod Biol; 2021 Sep; 264():281-288. PubMed ID: 34352424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic Importance of Inflammatory Indexes in Patients Treated by Pazopanib for Soft Tissue Sarcoma.
    Koseci T; Haksoyler V; Olgun P; Ata S; Nayir E; Duman BB; Cil T
    Clin Lab; 2022 Feb; 68(2):. PubMed ID: 35142203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.